CORT

#1372
Corcept Therapeutics Inc.
43.9100 USD
+0.53%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
43.6500
44.1300
Rango anual
28.6601
89.0000
Cambio diario
+0.53%
Variación mensual
+35.69%
Variación en los últimos 6 meses
-40.15%
Cambio anual
-40.15%
Cierres anteriores
43.6800
Abrir
44.1100
Bid
Ask
Mínimo
43.6500
High
44.1300
Volumen
491
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 4.6709 B
  • Employee 730
  • Founded 1998
  • CEO N/A
  • Website www.corcept.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKJG33
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
42.44
Relación precio/flujo de caja
5.48

Corcept Therapeutics Incorporated

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Noticias